← Back to all trials
Completed
NCT05417334
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 12 Months Postpartum.
Conditions: Dyspareunia
Sex: Female
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Hospital Clinic of Barcelona
Location: Hospital Clinic Barcelona Barcelona Barcelona
Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 12 months postpartum.
Eligibility Criteria
Inclusion Criteria:
* 4-12 postpartum
* de novo dyspareunia after delivery
* obstetric injury
* Grant informed consent
Exclusion Criteria:
* radiofrequency contraindications (pacemaker, active infection or pregnancy)
* cesarean section
* dyspareunia previous to labour
* previous vulvo-vaginal pathology
* patients with postpartum depression
* patients with a pelvic region oncological history
* patients with a history of pelvic trauma
Source: ClinicalTrials.gov (NCT05417334). StuddyBuddy aggregates publicly available trial information.
